Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

MAFG-AS1 is a novel clinical biomarker for clinical progression and unfavorable prognosis in gastric cancer

20 Feb 2020

Abstract excerpt

MAFG antisense 1 (MAFG-AS1) is recently identified as a novel lncRNA and serves as a tumor promoter in several types of human tumor. However, no prior study has been performed to evaluate the role of MAFG-AS1 in gastric cancer. In our study, we found MAFG-AS1 expression was increased in gastric cancer tissue samples compared with normal gastric mucosa tissue samples, and associated with poor overall survival in...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer-related molecular mechanisms research
Share to Helicobacter pylori-related gastroenterology studies
Share to RNA modifications and cancer

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 32079456
DOI: 10.1080/15384101.2020.1728017

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

MAFG-AS1 is a novel clinical biomarker for clinical progression and unfavorable prognosis in gastric cancerPMID 32079456Read ↗

Increased lncRNA AFAP1-AS1 expression predicts poor prognosis and promotes malignant phenotypes in gastric cancer.Semantic proximity Read ↗

Expression and clinical significance of long non-coding RNA HNF1A-AS1 in human gastric cancerSemantic proximity Read ↗

Long non-coding RNA LGALS8-AS1 facilitates PLAGL2-mediated malignant phenotypes in gastric cancer.Semantic proximity Read ↗

Upregulated expression of MNX1-AS1 long noncoding RNA predicts poor prognosis in gastric cancerSemantic proximity Read ↗

Abnormally expressed long noncoding RNA B3GALT5‐AS1 may serve as a biomarker for the diagnostic and prognostic of gastric cancerSemantic proximity Read ↗

The role of long non-coding RNA FGD5-AS1 in cancerSemantic proximity Read ↗

LncRNA DLGAP1-AS2 Overexpression Associates with Gastric Tumorigenesis; A Promising Diagnostic and Therapeutic TargetSemantic proximity Read ↗

LncRNA MSC-AS1 Is a Diagnostic Biomarker and Predicts Poor Prognosis in Patients With Gastric Cancer by Integrated Bioinformatics AnalysisSemantic proximity Read ↗

LncRNA PROX1-AS1 Facilitates Gastric Cancer Progression via miR-877-5p/PD-L1 AxisSemantic proximity Read ↗

Clinical significance, functional role and correlation with SEMA3B of long non-coding RNA SEMA3B-AS1 in gastric adenocarcinomaSemantic proximity Read ↗

lncRNA LUCAT1 acts as a potential biomarker and demonstrates malignant biological behaviors in gastric cancerlncRNA LUCAT1 acts as a potential biomarker and demonstrates malignant biological behaviors in gastric cancerSemantic proximity Read ↗

Correlation of MIF-AS1 polymorphisms with the risk and prognosis of gastric cancer.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.